LabGenomics Co. Ltd (084650) — Financial Flexibility Index
LabGenomics Co. Ltd (084650) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of ₩-5.93 Billion (operating CF ₩-6.41 Billion minus capex ₩480.02 Million) represents 0% of total liabilities (₩76.00 Billion). Check 084650 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LabGenomics Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for LabGenomics Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see LabGenomics Co. Ltd (084650) cash conversion ratio.
Annual Financial Flexibility Index for LabGenomics Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for LabGenomics Co. Ltd. Explore 084650 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | ₩-8.45 Billion | ₩-12.99 Billion | ₩79.35 Billion | ▼ -219.2% |
| 2023 | 0.09x | ₩7.62 Billion | ₩2.42 Billion | ₩85.31 Billion | ▼ -96.6% |
| 2022 | 2.62x | ₩108.20 Billion | ₩69.87 Billion | ₩41.32 Billion | ▲ +54.2% |
| 2021 | 1.70x | ₩79.08 Billion | ₩65.36 Billion | ₩46.57 Billion | ▲ +0.4% |
| 2020 | 1.69x | ₩47.07 Billion | ₩46.37 Billion | ₩27.82 Billion | ▲ +760.2% |
| 2019 | 0.20x | ₩3.75 Billion | ₩3.19 Billion | ₩19.06 Billion | ▲ +26.8% |
| 2018 | 0.16x | ₩2.64 Billion | ₩608.03 Million | ₩16.99 Billion | ▼ -16.3% |
| 2017 | 0.19x | ₩3.25 Billion | ₩-1.06 Billion | ₩17.52 Billion | ▼ -49.1% |
| 2016 | 0.36x | ₩6.62 Billion | ₩2.54 Billion | ₩18.17 Billion | ▼ -50.4% |
| 2015 | 0.73x | ₩7.00 Billion | ₩2.38 Billion | ₩9.54 Billion | ▲ +66.4% |
| 2014 | 0.44x | ₩4.35 Billion | ₩3.15 Billion | ₩9.86 Billion | — |